Skip to content

FINACKET

Active Risk: not assessed
Private limited companyfounded 20196 yrs activeMierendonkstraat 25, 1850 Grimbergen, BelgiumKBO/BCE: BE 0737.567.313
Summary

FINACKET is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €43,640 and a net result of -€48,327. Equity is growing by ~8.9% per year across the filed fiscal years. Its solvency ranks better than 14% of 3002 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.

History

On 8 November 2019, FINACKET was incorporated as a Private limited company.1 Total assets went from €176,237 in 2020 to €719,800 in 2025 and headcount from 1.1 full-time equivalents in 2022 to 2.7 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2020, 2022 and 2025

Acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
16-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Weakest financial yearnet -€48,327
Net result drops to -€48,327, the lowest in the series.
17-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
21-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
12-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Highest result since 2020net €42,227 ▲23.8%
Operating result €55,416, net result €42,227, both a record.
14-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Liquidity doublescurrent ratio 1.22
Current ratio from 0.55 to 1.22; short-term debt falls from €51,505 to €42,257.
14-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.